Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for sensitive data.
This move became public after a official document dated December was disclosed, which showed President Emmerson Mnangagwa believed the deal was "skewed".
An official representative later explained that the United States was seeking biological samples for research and commercial purposes but refused to share the benefits from any future vaccines.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further negotiations to reach a deal acceptable to both sides so the nation's vital HIV treatment initiative can continue.
Broader Background
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement following concerns were raised about the security of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and accountability.
According to reports, Sixteen African countries have to date signed these new agreements, representing over $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to share its genetic material and health information over an extended period, with no equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our citizens if a new pandemic arise."
National Interest and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral deals were undermining frameworks previously established through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This system is intended to guarantee that when a nation contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how future co-operation could be arranged in a way that respects the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that negotiations should continue given that a large portion of the country's HIV programmes depended on external financing.
"Where specific concerns exist, such as those involving information security or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," the group said.
The halted deal underscores the complex tensions between receiving crucial foreign assistance and safeguarding a country's data in an ever more interconnected world.